Hypoglycemic Agents [Pharmacological Action]
Tree Number(s): D007004
MeSH Unique ID: D007004
- insulin, neutral (Supplementary Concept)
- allicin (Supplementary Concept)
- alliin (Supplementary Concept)
- diphenyleneiodonium (Supplementary Concept)
- glucuronyl glucosamine glycan sulfate (Supplementary Concept)
- phenyl biguanide (Supplementary Concept)
- gliquidone (Supplementary Concept)
- methyl 2-tetradecylglycidate (Supplementary Concept)
- 2-tetradecylglycidic acid (Supplementary Concept)
- 2-bromopalmitate (Supplementary Concept)
- inositol phosphate glycan (Supplementary Concept)
- meglitinide (Supplementary Concept)
- copper bis(3,5-diisopropylsalicylate) (Supplementary Concept)
- AICA ribonucleotide (Supplementary Concept)
- midaglizole (Supplementary Concept)
- ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate (Supplementary Concept)
- vanadyl sulfate (Supplementary Concept)
- gusperimus (Supplementary Concept)
- BRL 26830A (Supplementary Concept)
- ciglitazone (Supplementary Concept)
- ponalrestat (Supplementary Concept)
- miglitol (Supplementary Concept)
- emeriamine (Supplementary Concept)
- etomoxir (Supplementary Concept)
- fenugreek seed meal (Supplementary Concept)
- glimepiride (Supplementary Concept)
- englitazone (Supplementary Concept)
- zopolrestat (Supplementary Concept)
- peroxovanadate (Supplementary Concept)
- repaglinide (Supplementary Concept)
- glibornuride (Supplementary Concept)
- disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate (Supplementary Concept)
- mitiglinide (Supplementary Concept)
- 2,4-thiazolidinedione (Supplementary Concept)
- voglibose (Supplementary Concept)
- pramlintide (Supplementary Concept)
- insulin glulisine (Supplementary Concept)
- alogliptin (Supplementary Concept)
- isophane insulin, insulin lispro drug combination 50:50 (Supplementary Concept)
- insulin aspart, insulin aspart protamine drug combination 30:70 (Supplementary Concept)
- insulin, pork; isophane insulin, pork drug combination 30:70 (Supplementary Concept)
- insulin, regular, beef-pork (Supplementary Concept)
- Insulin, Globin Zinc (Supplementary Concept)
- isophane insulin, beef (Supplementary Concept)
- isophane insulin, beef-pork (Supplementary Concept)
- isophane insulin, pork (Supplementary Concept)
- insulin, protamine zinc, beef-pork (Supplementary Concept)
- 5-hydroxysaxagliptin (Supplementary Concept)
- insulin degludec, insulin aspart drug combination (Supplementary Concept)
- 5,7-dihydroxy-6,8-dimethyl-4'-methoxyflavone (Supplementary Concept)
- 8-(2-hydroxypropan-2-yl)-5-hydroxy-7-methoxy-6-methyl-4'-methoxyflavone (Supplementary Concept)
- 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid (Supplementary Concept)
- PAZ320 (Supplementary Concept)
- velagliflozin (Supplementary Concept)
- MR1704 (Supplementary Concept)
- MK-2640 (Supplementary Concept)
- S009-0629 (Supplementary Concept)
- Xultophy (Supplementary Concept)
- MYL-1501D (Supplementary Concept)
- volagidemab (Supplementary Concept)
- firuglipel (Supplementary Concept)
- bexagliflozin (Supplementary Concept)
- efpeglenatide (Supplementary Concept)
- 8-(2-aminophenyl)-3-butyl-1,6,7-trimethyl-1H-imidazo(2,1-f)purine-2,4(3H,8H)-dione (Supplementary Concept)
- Acetohexamide (MeSH Term)
- Biguanides (MeSH Term)
- Buformin (MeSH Term)
- Butoxamine (MeSH Term)
- Carbutamide (MeSH Term)
- Chlorpropamide (MeSH Term)
- Glyburide (MeSH Term)
- Gliclazide (MeSH Term)
- Glipizide (MeSH Term)
- Insulin (MeSH Term)
- Insulin, Isophane (MeSH Term)
- Metformin (MeSH Term)
- Phenformin (MeSH Term)
- Tolazamide (MeSH Term)
- Tolbutamide (MeSH Term)
- Insulin, Long-Acting (MeSH Term)
- Biphasic Insulins (MeSH Term)
- Insulin, Short-Acting (MeSH Term)
- Insulin Aspart (MeSH Term)
- Insulin Lispro (MeSH Term)
- Insulin, Regular, Pork (MeSH Term)
- Insulin, Lente (MeSH Term)
- Insulin, Ultralente (MeSH Term)
- Isophane Insulin, Human (MeSH Term)
- Sitagliptin Phosphate (MeSH Term)
- Insulin Glargine (MeSH Term)
- Insulin Detemir (MeSH Term)
- Linagliptin (MeSH Term)
- Rosiglitazone (MeSH Term)
- Pioglitazone (MeSH Term)
- Topiramate (MeSH Term)
- Troglitazone (MeSH Term)
- Vildagliptin (MeSH Term)
- Nateglinide (MeSH Term)
- semaglutide (Supplementary Concept)
- dulaglutide (Supplementary Concept)
- rGLP-1 protein (Supplementary Concept)
- conduritol B (Supplementary Concept)
- N-nonyl-1-deoxynojirimycin (Supplementary Concept)
- salicortin (Supplementary Concept)
- castanospermine (Supplementary Concept)
- 5-amino-5-deoxygluconic acid delta-lactam (Supplementary Concept)
- trestatin (Supplementary Concept)
- dihydroacarbose (Supplementary Concept)
- phenyl-6-deoxy-6-(morpholin-4-yl)glucopyranoside (Supplementary Concept)
- 3-O-digalloyl-1,2,4,6-tetra-O-galloylglucose (Supplementary Concept)
- N-phenyl-4,5,6,7-tetrachlorophthalimide (Supplementary Concept)
- 13-hydroxykompasinol A (Supplementary Concept)
- scirpusin C (Supplementary Concept)
- acarviosinyl-(1-9)-3-glucopyranosylpropene (Supplementary Concept)
- valienamine (Supplementary Concept)
- 6-methyl-3-hydroxypiperidine-2-carboxylic acid (Supplementary Concept)
- rubasperone A (Supplementary Concept)
- rubasperone B (Supplementary Concept)
- butyl isobutyl phthalate (Supplementary Concept)
- 1,4-dideoxy-1,4-((2,3,4,5,6-pentahydroxyhexyl)episulfoniumylidene)arabinitol (Supplementary Concept)
- pycnalin (Supplementary Concept)
- pradimicin Q (Supplementary Concept)
- lonchocarpene (Supplementary Concept)
- 3,5-dimethoxy-4'-O-prenyl-trans-stilbene (Supplementary Concept)
- ginnalin A (Supplementary Concept)
- jamutannin B (Supplementary Concept)
- jamutannin A (Supplementary Concept)
- iso-oenothein C (Supplementary Concept)
- epigallocatechin-3-O-gallate epigallocatechin dimer (Supplementary Concept)
- 24,25,26,27-tetranor-apotirucalla-(apoeupha)-1-senecioyloxy-3,7-dihydroxy-14,20,22-trien-21,23-epoxy (Supplementary Concept)
- pistagremic acid (Supplementary Concept)
- polyflavanostilbene A (Supplementary Concept)
- deoxyvalidamine (Supplementary Concept)
- 2,3,4,5,6-pentagalloylglucose (Supplementary Concept)
- 4-O-glucopyranosylmoranoline (Supplementary Concept)
- miglustat (Supplementary Concept)
- nigrosporamide A (Supplementary Concept)
- dihydropyrano(3,2-c)quinoline (Supplementary Concept)
- dorsilurin F (Supplementary Concept)
- schulzeine A (Supplementary Concept)
- 6-aminocyclohex-4-ene-1,2,3-triol (Supplementary Concept)
- purunuside A (Supplementary Concept)
- purunuside B (Supplementary Concept)
- purunuside C (Supplementary Concept)
- isoacarbose (Supplementary Concept)
- acarviosine-glucose (Supplementary Concept)
- 7-deoxycastanospermine (Supplementary Concept)
- CM-10-18 compound (Supplementary Concept)
- 6-amino-pyrido(2,3-d)pyrimidine-2,4-dione (Supplementary Concept)
- lamesticumin G (Supplementary Concept)
- TMC 2B (Supplementary Concept)
- TMC 2C (Supplementary Concept)
- diprotin A (Supplementary Concept)
- N-alanylproline-O-(4-nitrobenzoyl)hydroxylamine (Supplementary Concept)
- saxagliptin (Supplementary Concept)
- 1-(((2-((5-cyanopyridin-2-yl)amino)ethyl)amino)acetyl)-2-cyano-(S)-pyrrolidine (Supplementary Concept)
- 4-(8-methyl-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine (Supplementary Concept)
- 4-(8-(4-fluorobenzyl)-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine (Supplementary Concept)
- 1-((6-hydroxy-2-azabicyclo(2.2.1)hept-3-yl)carbonyl)-2-pyrrolidinecarbonitrile (Supplementary Concept)
- lipoyl vildagliptin (Supplementary Concept)
- anagliptin (Supplementary Concept)
- 1-(((1-(hydroxymethyl)cyclopentyl)amino)acetyl)pyrrolidine-2,5-dicarbonitrile (Supplementary Concept)
- 3-amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-(1,2,4)triazolo(1,5-a)pyridin-6-ylphenyl)butanamide (Supplementary Concept)
- sulphostin (Supplementary Concept)
- 1-(2'-amino-3',3'-dimethylbutanoyl)pyrrolidine-2-carbonitrile (Supplementary Concept)
- 3-amino-4-(2,4,5-trifluorophenyl)-N-(4-(6-(2-methoxyethoxy)benzothiazol-2-yl)tetrahydropyran-4-yl)butanamide (Supplementary Concept)
- (3,3-difluoropyrrolidin-1-yl)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl)methanone (Supplementary Concept)
- ABT 341 (Supplementary Concept)
- 4-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one (Supplementary Concept)
- 3-amino-1-(1-boronic-ethyl)pyrrolidine-2-one (Supplementary Concept)
- NN 7201 (Supplementary Concept)
- methionyl-2-cyanopyrrolidine (Supplementary Concept)
- 1-(2-(5-cyano-2-pyridinylamino)ethylamino)acetyl-2-pyrrolidinecarbonitrile (Supplementary Concept)
- 1-(4-aminomethyl-4-(3-chlorophenyl)cyclohexyl)-tetrahydropyrimidin-2-one (Supplementary Concept)
- Syrrx 106124 (Supplementary Concept)
- dapagliflozin (Supplementary Concept)
- remogliflozin etabonate (Supplementary Concept)
- empagliflozin (Supplementary Concept)
- ertugliflozin (Supplementary Concept)
- ipragliflozin (Supplementary Concept)
- 6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol (Supplementary Concept)
- (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol (Supplementary Concept)
- licogliflozin (Supplementary Concept)
- sergliflozin etabonate (Supplementary Concept)
- Liraglutide (MeSH Term)
- Exenatide (MeSH Term)
- Acarbose (MeSH Term)
- Islet Amyloid Polypeptide (MeSH Term)
- Canagliflozin (MeSH Term)